Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

Summary

This will be a randomized, double blind, placebo controlled, 2 arm, parallel group, methodology study to assess the effect of 6 weeks of liraglutide administration on food intake in obese subjects.

Timeline

Start

2017-02-20

Primary completion

2018-01-16

Completion

2018-01-16

Outcome

Met primary endpoint

registry analysis (superiority test); Liraglutide vs Placebo; p = 0.0000; Least Square Mean Difference -235.75 (95% CI -322.25 to -149.25) NCT03041792 ↗

registry analysis (superiority test); Liraglutide vs Placebo; p = 0.0000; Least Square Mean Difference -243.63 (95% CI -339.10 to -148.15) NCT03041792 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Liraglutide	Peptide	—	—

Indications